Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2881078 in older adults with COPD and muscle weakness participating in home exercise
2017-001148-37Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing GSK2881078 with Placebo (2 arms). Primary endpoint: Safety and tolerability. Started Nov 2017; status: completed.
02
Drugs
GSK2881078
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2017-001148-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001148-37.